We report a series of new heterocyclic compounds containing the imidazole scaffold were synthesized such as 2-(furan-2-yl)-1-(piperidine-4-yl)-1H-benzo[d]imidazole derivative. Due to the biological activities of imidazole as antimicrobial agents, in the present work, all the synthesized compounds were characterized by 1 H NMR and LC-MS analysis and some of the compounds are characterized by 13 C NMR. All the synthesized compounds were evaluated for their antimicrobial activity against Gram +ve and Gram -ve bacteria and different fungal species which demonstrated good to moderate antimicrobial activity, in which compounds 7b and 7l shows highest antimicrobial activity.
Introduction
Heterocycles of benzimidazole are important substructures identified in natural products and pharmacologically active molecules. [1] [2] [3] [4] [5] A different derivative of imidazole act as an inhibitor of p38 MAP kinase, 6 glucagon receptors, 7 plant growth regulators, 8 therapeutic agents, 9 antibacterial, 10 and also antitumor, 11 some of the derivatives used as an ionic liquid which highly benefits to the green chemistry. The synthesis of benzimidazole derivatives plays important role in the biological activities of these compounds induced by the heterocyclic ring. Benzimidazole derivatives display a wide range of biological and pharmaceutical active such as antiulcer activity antimicrobial, antiviral, antidiabetic and anticancer activity.
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Figure 1.
Representative examples of some drugs containing a benzimidazole moiety.
Commonly benzimidazole synthesized by condensation with carboxylic acids or their functional derivatives and o-aminoanilines. [18] [19] [20] [21] [22] [23] [24] Drawbacks of these conditions are dehydrating reaction conditions, high temperature, and very strong acid catalysts. Intramolecular cyclization of o-bromoaryl derivatives in the presence of copper(II)oxide nanoparticles in solvent DMSO, 25 and the intramolecular cyclocondensation of some aryl amino oximes by using of methane sulfonyl chloride and triethylamine 26 can also be used to produce benzimidazole derivatives. However, all these synthetic routes require expensive metal catalysts, toxic solvents. Due to diverse range of biological activity and use of benzimidazole derivative in material chemistry and use as ionic solvent development of new synthetic method is an important area. We have synthesized novel benzimidazole derivatives in four steps via reductive cyclization of n-piperidine substituted nitroaniline with 2-furfuryl using sodium dithionite 27, 28 and piperidine amine coupling with commercially available acid, acyl chloride, and sulphonyl chloride.
Results and Discussion
In this work we describe the synthesis of amide and sulphonamide derivative of 2-(furan-2-yl)
imidazole from n-substituted benzene diamine. Spectral data and physical data of this respectively. All the bacterial and fungal suspensions were equally spread onto the sterile Muller Hinton and PDA respectively with the help of sterile swabs. Wells were made in the plates (1 cm) with the help of sterile cork borer. The standard antibiotics were dissolved in sterile distilled water up to 200 µg/mL of final concentration. The culture to be tested was dissolved in DMSO up to the final concentration of 1 mg/mL and 0.1 mL of it was loaded into the well. The plate was incubated at 4 ᵒC for 20 minutes for proper diffusion of chemical and then the plates were incubated in upward position for 24 hrs at 37 ᵒC for bacterial culture and 48 hrs at 25 ᵒC for fungal cultures. The control activity against DMSO was also performed. After an incubation zone of inhibition was observed and measured. Afterwards water (100 mL) was added and resulting mixture was extracted with ethyl acetate (3 × 50 mL). The combine organic were dried over (Na 2 SO 4 ) and concentrated to dryness. The remaining crude mixture was chromatographed on a silica gel column using EtOAc/n-hexane (3:7) to give 3 as a yellow liquid (4.7 g, 70% 
tert-Butyl 4-(2-(furan-2-yl)-1H-benzo[d]imidazol-1-yl)piperidine-1-carboxylate (5)
. tert-Butyl 4-((2-nitrophenyl)amino)piperidine-1-carboxylate 3 (3.0 g, 9.33 mmol) and furan-2-carbaldehyde 4 (0.897 g, 9.33 mmol) was added to methanol (30 mL), and Na 2 S 2 O 4 (4.87 g, 27.66 mmol) with water (30 mL) and reaction was heated at 70 ᵒC for 16 h. Concentrated the reaction mixture and added water (100 mL) solid was precipitated filter it and dry it under vacuum to give 5 (3.0 g, 87.4%) as a white solid. 1 4 and concentrated in vacuum. The crude product was purified by column chromatography on silica gel (eluent: 0-60% n-Hexane/EtOAc) to afford the product (3,5- 4 and concentrated in vacuum. The crude product was purified by column chromatography on silica gel (eluent: 0-70% n-Hexane/EtOAc) to afford the product 4- (4-(2-(furan-2-yl) 170 mg 130 and dried over anhydrous Na 2 SO 4 and concentrated in vacuum. The crude product was purified by column chromatography on silica gel (eluent: 0-50% DCM/EtOAc) to afford the product 1- 
2-(Furan-2-yl)-1-(piperidin-4-yl)-1H-benzo[d]imidazole hydrochloride (6). tert-Butyl
4-(2-(furan-2-yl)-1H- benzo[d]imidazol-1-yl)piperidine-1-(4-(2-(Furan-2-yl)-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)(furan-3-yl)methanone (7a). 2-(Furan-2-yl)-1- (piperidin-4-yl)-1H-benzo[d]imidazoledichlorophenyl)(4-(2- (furan-2-yl)-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)methanone
4-(4-(2-(Furan-2-yl)-1H-benzo[d]imidazol-1-yl)piperidine-1-carbonyl)benzenesulfonamide (7d).
(1- (cyclopropylsulfonyl)piperidin-4-yl)-2-(furan-2-yl)-1H-benzo[d]
